$0.576
+0.062 (+10.71%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de KTTA por análisis de gráficos similares
Alphio's KTTA stock price prediction model matches the current Pasithea Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.57 (-1.04%). The 1-week path is $0.57 (-0.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Pasithea Therapeutics Corp?
Pasithea Therapeutics Corp (KTTA) is a good buy right now due to its recent price increase of 55.51% over the last 5 days and the positive momentum indicated by an RSI of 81.843, suggesting strong buying pressure. The company has also received FDA clearance for its PAS-004 candidate, which could significantly enhance its market position in treating NF1-associated tumors. However, it is important to note that the company has a negative net income of -5,273,852 USD in Q2 2026, which poses a risk to its financial stability.
KTTA cerró en $0.58 el Friday, tras subir +10.71%
Pasithea Therapeutics Corp (KTTA) last closed at $0.5757, gaining +10.71%. These facts feed the 1-day and 1-week KTTA price prediction above.
Factores de la previsión
Los factores de la previsión de Pasithea Therapeutics Corp (KTTA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de KTTA, ordenadas por similitud.
Análisis de estacionalidad de KTTA
Historically the probability of a positive November return for KTTA is 0.00%. April offers the highest probability of a positive month at 7.81%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de KTTA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.61 | $0.74 | $0.75 | +28.48% |
| Dec 2026 | $0.78 | $0.83 | $0.95 | +43.76% |
En 2026, se proyecta que Pasithea Therapeutics Corp (KTTA) oscile entre $0.61 y $0.95.
Previsión mensual de Pasithea Therapeutics Corp para 2026
En Nov de 2026, se proyecta que Pasithea Therapeutics Corp promedie $0.74, con un mínimo de $0.61 y un máximo de $0.75.
En Dec de 2026, se proyecta que Pasithea Therapeutics Corp promedie $0.83, con un mínimo de $0.78 y un máximo de $0.95.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.